http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0973506-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6abe8f4287ebbb10ee4e7ddb8eb0e40a |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-485 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
filingDate | 1998-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2002-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a02a8e841826082fef0557734786e87 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fc4325bf16e4d8005201b3000fdb3ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_152e660da6bc8ba0b33068327052aa01 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5e2e5fd28328be43aeeecb3581a087fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9ecf8b7679639802f2b78bf438c55daf |
publicationDate | 2002-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-0973506-B1 |
titleOfInvention | Process for preparing solid pharmaceutical dosage forms |
abstract | This invention relates to a process for the preparation of an oral solid rapidly disintegrating dosage form of a pharmaceutically active substance which has an unacceptable taste which process comprises: (i) forming a solution or a suspension in a solvent of a water soluble or water dispersible carrier, a filler and the pharmaceutically active substance with the unacceptable taste in association with a lipid, the weight ratio of the pharmaceutically active substance to the lipid being in the range of from 1:1 to 1:10 and the weight ratio of the carrier to the lipid being in the range of from 5:1 to 1:15; (ii) forming discrete units of the suspension or solution; and (iii) removing the solvent from the discrete units under conditions whereby unit dosages are formed comprising a network of carrier/filler carrying a dosage of the pharmaceutically active substance in association with the lipid; oral solid rapidly disintegrating dosage forms prepared by such a process are also provided. |
priorityDate | 1997-02-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 91.